✦ LIBER ✦

A Threshold Hazard Model for Estimating Serious Infection Risk Following Anti-Tumor Necrosis Factor Therapy in Rheumatoid Arthritis Patients

✍ Scribed by Fu, Bo; Lunt, Mark; Galloway, James; Dixon, Will; Hyrich, Kimme; Symmons, Deborah

Book ID: 120717506
Publisher: Taylor and Francis Group
Year: 2013
Tongue: English
Weight: 392 KB
Volume: 23
Category: Article
ISSN: 1054-3406
DOI: 10.1080/10543406.2011.616973

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti–tumor necrosis factor α therapy and

Anti–tumor necrosis factor α therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis

✍ Sebastian Schneeweiss; Soko Setoguchi; Michael E. Weinblatt; Jeffrey N. Katz; Je 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 1 views

## Abstract ## Objective To assess the association between the initiation of anti–tumor necrosis factor α (anti‐TNFα) therapy and the risk of serious bacterial infections in routine care. ## Methods This was a cohort study of patients with rheumatoid arthritis (RA) in whom specific disease‐modif

Serious infection following anti–tumor n

Serious infection following anti–tumor necrosis factor α therapy in patients with rheumatoid arthritis: Lessons from interpreting data from observational studies

✍ W. G. Dixon; D. P. M. Symmons; M. Lunt; K. D. Watson; K. L. Hyrich; A. J. Silman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

Does Anti-Tumor Necrosis Factor- Therapy

Does Anti-Tumor Necrosis Factor- Therapy Affect Risk of Serious Infection and Cancer in Patients with Rheumatoid Arthritis?: A Review of Longterm Data

✍ KEYSTONE, E. C. 📂 Article 📅 2011 🏛 Journal of Rheumatology Publishing Company 🌐 English ⚖ 355 KB

Risk of Significant Infection in Rheumat

Risk of Significant Infection in Rheumatoid Arthritis Patients Switching Anti-Tumor Necrosis Factor-α Drugs

✍ Bao-Anh Nguyen-Khoa; Earl L. Goehring Jr.; Kimberly A. Alexander; Wei Dong; Pave 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 421 KB

Use of a disease risk score to compare s

Use of a disease risk score to compare serious infections associated with anti–tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patients

✍ Jeffrey R. Curtis; Fenglong Xie; Lang Chen; Paul Muntner; Carlos G. Grijalva; Cl 📂 Article 📅 2012 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 257 KB

Prophylaxis for Latent Tuberculosis Infe

Prophylaxis for Latent Tuberculosis Infection Prior to Anti-Tumor Necrosis Factor Therapy in Low-Risk Elderly Patients With Rheumatoid Arthritis: A Decision Analysis

✍ Hazlewood, Glen S. ;Naimark, David ;Gardam, Michael ;Bykerk, Vivian ;Bombardier, 📂 Article 📅 2013 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 823 KB